A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of EB05 + SOC vs. Placebo + SOC in Adult Hospitalized Patients With COVID-19
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT04401475 |
|
Recruitment Status : Unknown
Verified April 2021 by Edesa Biotech Inc..
Recruitment status was: Recruiting
First Posted : May 26, 2020
Last Update Posted : May 3, 2021
|
Sponsor:
Edesa Biotech Inc.
Collaborator:
JSS Medical Research Inc.
Information provided by (Responsible Party):
Edesa Biotech Inc.
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Unknown |
|---|---|
| Estimated Primary Completion Date : | April 2021 |
| Estimated Study Completion Date : | April 2021 |